Clinical Sciences, Inc.: FDA filings under this applicant name
FDA lists 30 510(k) clearances under the applicant name “Clinical Sciences, Inc.” (first 1977, latest 1990), across 22 product codes in 4 review panels. Median 510(k) review time under this name: 78 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| DAA | Igg, Peroxidase, Antigen, Antiserum, Control | 3 | 3 |
| DHN | Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control | 2 | 2 |
| GQO | Antisera, Cf, Herpesvirus Hominis 1,2 | 2 | 2 |
| JTY | Culture Media, For Isolation Of Pathogenic Neisseria | 2 | 2 |
| LGD | Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii | 2 | 2 |
| LLM | Test, Antigen, Nuclear, Epstein-Barr Virus | 2 | 2 |
| LSE | Epstein-Barr Virus, Other | 2 | 2 |
| CFE | Electrophoretic, Lactate Dehydrogenase Isoenzymes | 1 | 1 |
| DBE | Antismooth Muscle Antibody, Indirect Immunofluorescent, Antigen, Control | 1 | 1 |
| DBM | Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control | 1 | 1 |
Plus 12 more product codes.
Review panels
- Microbiology (21)
- Immunology (4)
- Pathology (3)
- Clinical Chemistry (2)
Most recent Clinical Sciences, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K900688 | VARICELLA ZOSTER IGG CLIN-ELISA TEST KIT | LFY | 1990-05-15 | 91 |
| K883871 | EPSTEIN-BARR VIRAL CAPSID ANTIGEN IGM #5590 | LSE | 1989-07-14 | 304 |
| K883870 | EPSTEIN-BARR VIRAL CAPSID ANTIGEN IGG #4590 | LSE | 1989-07-14 | 304 |
| K891990 | RUBEOLA IGG CLIN-ELISA TEST SYSTEM, CAT. #4600 | LJB | 1989-06-15 | 79 |
| K883601 | EPSTEIN-BARR VIRUS (EBNA-1) IGM CATA. #5550 | LLM | 1989-05-11 | 261 |
| K883600 | EPSTEIN-BARR VIRUS (EBNA-1) IGG CATA. #4550 | LLM | 1989-05-11 | 261 |
| K874594 | TOXOPLASMA IGM CLIN-ELISA(TM) CAT # 5560 | LGD | 1988-03-07 | 119 |
| K872942 | IGM CMV CLIN-ELISA(TM) TEST SYSTEM NUMBER: 5530 | LKQ | 1988-01-11 | 168 |
| K860145 | RUBELLA ELISA TEST SYSTEM CATALOG NUMBER: 4540 | LFX | 1986-07-14 | 180 |
| K860773 | TOXOPLASMA IGG CLIN-ELISA TEST KIT CAT. NO. 4560 | LGD | 1986-05-23 | 81 |
20 earlier clearances. See the full list in Caduvo.
Recalls
FDA recall records list no recalls under a recalling firm named Clinical Sciences, Inc..
3 product recalls in 3 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Diasorin Inc. (3).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Clinical Data, Inc. (37 510(k)s)
- Clinical Assays, Inc. (27 510(k)s)
- Clinical Controls, Inc. (18 510(k)s)
- Clinical Resources, Inc. (14 510(k)s)
- Clinical Technology Corp. (12 510(k)s)
- Clinical Connections, Inc. (10 510(k)s)
- Clinical Innovations, Inc. (9 510(k)s)
- Clinical Innovations, LLC (9 510(k)s)
- Clinical Diagnostics, Inc. (8 510(k)s)
- Clinical Convenience Products, Inc. (6 510(k)s)
- Clinical Laserthermia Systems, AB (6 510(k)s)
- Clinical Neuro Systems, LLC (5 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Clinical Sciences, Inc.?
FDA lists 30 510(k) clearances under the applicant name “Clinical Sciences, Inc.” (first 1977, latest 1990), across 22 product codes in 4 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Clinical Sciences, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Clinical Sciences, Inc. is 78 days.
Which FDA product codes appear under Clinical Sciences, Inc.?
The most frequent FDA product codes under this applicant name are DAA (Igg, Peroxidase, Antigen, Antiserum, Control, 3); DHN (Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control, 2); GQO (Antisera, Cf, Herpesvirus Hominis 1,2, 2).
Next steps
- See all 30 Clinical Sciences, Inc. clearances with predicates and recalls
- Run predicate analysis for product code DAA, Clinical Sciences, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.